Levy S - Search Results

1

Postoperative radiotherapy in stage I-III Merkel cell carcinoma.

Levy S, Blankenstein SA, Grünhagen DJ, Jalving M, Hamming-Vrieze O, Been LB, Tans L, van Akkooi ACJ, Tesselaar MET. Levy S, et al. Radiother Oncol. 2022 Jan;166:203-211. doi: 10.1016/j.radonc.2021.11.017. Epub 2021 Nov 25. Radiother Oncol. 2022. PMID: 34838887 Free article.

2

Survival in Patients with Neuroendocrine Tumours of the Small Intestine: Nomogram Validation and Predictors of Survival.

Levy S, van Veenendaal LM, Korse CM, Breekveldt ECH, Verbeek WHM, Vriens MR, Kuhlmann KFD, van den Berg JG, Valk GD, Tesselaar MET. Levy S, et al. J Clin Med. 2020 Aug 3;9(8):2502. doi: 10.3390/jcm9082502. J Clin Med. 2020. PMID: 32756529 Free PMC article.

3

Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours.

Samsom KG, Levy S, van Veenendaal LM, Roepman P, Kodach LL, Steeghs N, Valk GD, Wouter Dercksen M, Kuhlmann KFD, Verbeek WHM, Meijer GA, Tesselaar MET, van den Berg JG. Samsom KG, et al. Among authors: levy s. Histopathology. 2021 Mar;78(4):556-566. doi: 10.1111/his.14252. Epub 2020 Nov 3. Histopathology. 2021. PMID: 32931025

4

Avelumab for advanced Merkel cell carcinoma in the Netherlands: a real-world cohort.

Levy S, Aarts MJB, Eskens FALM, Keymeulen KBMI, Been LB, Grünhagen D, van Akkooi A, Jalving M, Tesselaar MET. Levy S, et al. J Immunother Cancer. 2020 Sep;8(2):e001076. doi: 10.1136/jitc-2020-001076. J Immunother Cancer. 2020. PMID: 32948651 Free PMC article.

5

Well-Differentiated Bronchopulmonary Neuroendocrine Tumors: More Than One Entity.

van den Broek MFM, Levy S, Buikhuisen WA, Dijke K, Hartemink KJ, van Leeuwaarde RS, Vriens MR, Tesselaar MET, Valk GD; DutchMEN Study Group. van den Broek MFM, et al. Among authors: levy s. J Thorac Oncol. 2021 Nov;16(11):1810-1820. doi: 10.1016/j.jtho.2021.07.020. Epub 2021 Aug 2. J Thorac Oncol. 2021. PMID: 34352379 Free article.

6

First-line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma: a nationwide phase 2 single-arm clinical trial.

Levy S, Verbeek WHM, Eskens FALM, van den Berg JG, de Groot DJA, van Leerdam ME, Tesselaar MET. Levy S, et al. Ther Adv Med Oncol. 2022 Feb 27;14:17588359221077088. doi: 10.1177/17588359221077088. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35251315 Free PMC article.

7

Elevated Serotonin and NT-proBNP Levels Predict and Detect Carcinoid Heart Disease in a Large Validation Study.

Levy S, Kilgallen AB, Korse CM, Oerlemans MIFJ, Sluijter JPG, van Laake LW, Valk GD, Tesselaar MET. Levy S, et al. Cancers (Basel). 2022 May 10;14(10):2361. doi: 10.3390/cancers14102361. Cancers (Basel). 2022. PMID: 35625964 Free PMC article.

8

Primary Tumor Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumors (NETs): A Comparison of Upfront Surgical Resection Versus a Watch and Wait Strategy in Two Specialist NET Centers.

Levy S, Arthur JD, Banks M, Kok NFM, Fenwick SW, Diaz-Nieto R, van Leerdam ME, Cuthbertson DJ, Valk GD, Kuhlmann KFD, Tesselaar MET. Levy S, et al. Ann Surg Oncol. 2022 Nov;29(12):7822-7832. doi: 10.1245/s10434-022-12030-0. Epub 2022 Jul 16. Ann Surg Oncol. 2022. PMID: 35842528

9

[No title available]

[No authors listed] [No authors listed] PMID: 35906323

10

Four decades of experience with carcinoid heart disease: An analysis of 84 patients.

Levy S, Korse CE, de Groot ACA, Meijer RCA, Tesselaar MET, Valk GD. Levy S, et al. J Neuroendocrinol. 2022 Oct;34(10):e13199. doi: 10.1111/jne.13199. Epub 2022 Oct 18. J Neuroendocrinol. 2022. PMID: 36256859

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,260 results

Search Page